Corcept Therapeutics (CORT) Kev ntsuas ntawv
Corcept Therapeutics
AI kev txhais lus: CORT
AI tshaj tawm tus nqi hom phiaj rau hnub lag luam tom ntej, kawg lub lis thiab kawg hli. Kev hloov kho raug ntsuas los ntawm tus nqi tshiab. Cov no yog kev ntsuas xav tau, tsis yog kev pab cuam lag luam.
Nqi hauv 6 hli dhau los
Premium qhia AI lub hom phiaj nqi rau 1 hnub, 1 lim tiam thiab 1 hli rau tus no thiab txhua tus stock lwm tus.
Qhib Premium🔒 Kev ntsuas kev txav chav
Kev ntsuas kev txav chav — txhua kev ntsuas dhau los nyob ze rau qhov kawg tiag tiag — yog ib feem ntawm Premium.
Qhib PremiumTxog lub tuam txhab no
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the development of drugs for the treatment of serious metabolic and psychiatric disorders. The company’s main product modifies the action of cortisol, also known as the “stress hormone,” by blocking cortisol’s binding to one of two known receptors—the type 2 glucocorticoid receptor.
